Organisation paid for research Program year 2024 Source: CMS Open Payments

Balmiki, Rajeev, Office

Neither a doctor nor a teaching hospital

Research payments

$149,631

4 payments

Through program year 2024, Balmiki, Rajeev, Office is reported as receiving $149,631 in research payments, across 4 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2024	Research	$131,765	3
2021	Research	$17,865	1

Breakdown

Who paid Research payments · program years 2021–2024

AstraZeneca Pharmaceuticals LP $102,341 1 payment
Acerta Pharma LLC $28,389 2 payments
AstraZeneca UK Limited $18,900 1 payment

Studies the money was for Research payments · program years 2021–2024

Personalized Escalation of Consolidation Immunotherapy Following Chemoradiotherapy in Stage III NSCLC $102,341 1 payment
Tagrisso Testing Tx Patterns RWO early stage NSCLC $18,900 1 payment
A Study of ACP-196 (Acalabrutinib) in Subjects With Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy $17,865 1 payment
A Randomized, Multicenter, Open-Label, 3 Arm Phase 3 Study of Obinutuzumab in Combination with Chlorambucil, ACP-196 in Combination with Obinutuzumab, and ACP-196 Monotherapy in Subjects with Previously Untreated Chronic Lymphocytic Leukemia $10,524 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.